Niranjan Sardesai, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 43,600 shares at $9.30 ($405K) on 2016-08-29, disclosed to the SEC on 2016-08-30.
Open-market sale of $405k INO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.30 | 21,800 | $203K | 50.0% |
| 2 | $9.30 | 21,800 | $203K | 50.0% |
| Total | $9.30 avg | 43,600 | $405K | 100% |
| Filing → |
| INO | BUY | 2013-03-22 | $13K | — | Filing → |
| INO | BUY | 2012-05-17 | $5K | — | Filing → |